Zusammenfassung
Die Toxoplasmose ist eine weltweit vorkommende Zoonose. Sie wird durch das Protozoon Toxoplasma gondii, einen intrazellulären Erreger, hervorgerufen. Der Erreger wurde erstmals im Jahr 1908 als Parasit in einem Nagetier, dem Gondi, nachgewiesen und primär der Gattung der Leishmanien zugeordnet. Die erste Beschreibung einer Erkrankung beim Menschen erfolgte 1923 mit dem nachfolgenden Nachweis einer diaplazentaren Übertragung im Jahr 1939. Ende der 1960er Jahre erfolgte die vollständige Aufklärung des Entwicklungszyklus von Toxoplasma gondii.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Azevedo KM, Setubal S, Lopes VG, Camacho LA, Oliveira SA (2010) Congenital toxoplasmosis transmitted by human immunodeficiency-virus infected women. Braz J Infect Dis 14:186–189
Berrebi A, Kobuch WE, Bessieres MH, Bloom MC, Rolland M, Sarramon MF, Roques C, Fournie A (1994) Termination of pregnancy for maternal toxoplasmosis. Lancet 344:36–39
Boyer KM, Holfels E, Roizen N, Swisher C, Mack D, Remington J, Withers S, Meier P, McLeod R, Toxoplasmosis Study G (2005) Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening. Am J Obstet Gynecol 192:564–571
Cortina-Borja M, Tan HK, Wallon M, Paul M, Prusa A, Buffolano W, Malm G, Salt A, Freeman K, Petersen E, Gilbert RE (2010) Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med 7:
Djurkovic-Djakovic O (1995) Toxoplasma infection and pathological outcome of pregnancy. Gynecol Obstet Invest 40:36–41
Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R (1999) Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 353:1829–1833
Faucher B, Garcia-Meric P, Franck J, Minodier P, Francois P, Gonnet S, L’Ollivier C, Piarroux R (2012) Long-term ocular outcome in congenital toxoplasmosis: a prospective cohort of treated children. J Infect 64:104–109
Fernandes RC, Vasconcellos VP, Araujo LC, Medina-Acosta E (2009) Vertical transmission of HIV and toxoplasma by reactivation in a chronically infected woman. Braz J Infect Dis 13:70–71
Freeman K, Tan HK, Prusa A, Petersen E, Buffolano W, Malm G, Cortina-Borja M, Gilbert R (2008) Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study. Pediatrics 121:e1215–1222
Friese K, Schäfer A, Hof H (2003) Infektionskrankheiten in Gynäkologie und Geburtshilfe. Springer, Berlin
Friese K, Mörike K, Neumann G, Windorfer A (2009) Arzneimittel in der Schwangerschaft und Stillzeit: Ein Leitfaden für Ärzte und Apotheker. Wissenschaftliche Verlagsgesellschaft, Stuttgart
Gagliuso DJ, Teich SA, Friedman AH, Orellana J (1990) Ocular toxoplasmosis in AIDS patients. Trans Am Ophthalmol Soc 88:63–86 (discussion 86–68)
Garcia-Méric P, Franck J, Dumon H, Piarroux R (2010) Management of congenital toxoplasmosis in France: current data. Presse Med 39(5):530–538
Garly ML, Petersen E, Pedersen C, Lundgren JD, Gerstoft J (1997) Toxoplasmosis in Danish AIDS patients. Scand J Infect Dis 29:597–600
Gras L, Wallon M, Pollak A, Cortina-Borja M, Evengard B, Hayde M, Petersen E, Gilbert R (2005) Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Paediatr 94:1721–1731
Gross U (2004) Prevalence and public-health-aspects of toxoplasmosis. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 47:692–697
Groß U, Roos T, Friese K (2001) Toxoplasmose in der Schwangerschaft. Dt Ärztebl 98:3293–3300
Groß U, Hruzik A, Hlobil H (2009) Toxoplasmose und Schwangerschaft. Der Gynäkologe 42:793–798
Guerina NG (1994) Congenital infection with Toxoplasma gondii. Pediatr Ann 23:147–151
Hahn H, Kaufmann SHE, Schulz TF, Suerbaum S (2009) Medizinische Mikrobiologie und Infektiologie. Springer, Heidelberg
Hlobil H, Gültig K, Naser K, Nötzel K (1992) Konnatale Toxoplasma-Infektionen in Baden-Württemberg. Klin Lab :679–686
Hotop A, Hlobil H, Gross U (2012) Efficacy of rapid treatment initiation following primary Toxoplasma gondii infection during pregnancy. Clin Infect Dis 54(11):1545–1552
Jones MH, Sever JL, Baker TH, Hallatt JH, Goldenberg ED, Justus KM, Gilkeson MR (1969) Toxoplasmosis and abortion. Am J Obstet Gynecol 104:919–920
Jones JL, Dargelas V, Roberts J, Press C, Remington JS, Montoya JG (2009) Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis 49:878–884
Jones JL, Krueger A, Schulkin J, Schantz PM (2010) Toxoplasmosis prevention and testing in pregnancy, survey of obstetrician-gynaecologists. Zoonoses. Public Health 57:27–33
Kaiser K, van Loon AM, Pelloux H, Ferrandiz J, Picot S, Wallace P, Peyron F (2007) Multicenter proficiency study for detection of Toxoplasma gondii in amniotic fluid by nucleic amplification methods. Clinica Chimica Acta 375:99–103
Kieffer F, Wallon M, Garcia P, Thulliez P, Peyron F, Franck J (2008) Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis. Pediatr Infect Dis J 27:27–32
Lago EG, Conrado GS, Piccoli CS, Carvalho RL, Bender AL (2009) Toxoplasma gondii antibody profile in HIV-infected pregnant women and the risk of congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis 28:345–351
McLeod R, Boyer K, Karrison T, Kasza K, Swisher C, Roizen N, Jalbrzikowski J, Remington J, Heydemann P, Noble AG, Mets M, Holfels E, Withers S, Latkany P, Meier P (2006) Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis 42:1383–1394
Meroni V, Genco F (2008) Toxoplasmosis in pregnancy: evaluation of diagnostic methods. Parassitologia 50:51–53
Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363:1965–1976
Mylonas I, Friese K (2009) Infektionen in der Gynäkologie und Geburtshilfe. Elsevier Verlag – Urban, München
Olariu TR, Remington JS, McLeod R, Alam A, Montoya JG (2011) Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants. Pediatr Infect Dis J 30(12):1056–1061
Pappas G, Roussos N, Falagas ME (2009) Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol 39:1385–1394
Petersen E (2007) Prevention and treatment of congenital toxoplasmosis. Expert Rev Anti Infect Ther 5:285–293
Phan L, Kasza K, Jalbrzikowski J, Noble AG, Latkany P, Kuo A, Mieler W, Meyers S, Rabiah P, Boyer K, Swisher C, Mets M, Roizen N, Cezar S, Remington J, Meier P, McLeod R (2008) Longitudinal study of new eye lesions in treated congenital toxoplasmosis. Ophthalmology 115:553–559 (e558)
Reiter-Owona I (2005) Laboratory diagnosis of toxoplasmosis - possibilities and Limitations. J Lab Med 29:439–445
Remington J, McLeod R, Thulliez P, Desmonts G (2006) Toxoplasmosis. In: Remington J, Klein J, Wilson C, Baker C (Hrsg) Infectious diseases of the fetus and newborn infant, 6. Aufl. Elsevier Saunders,
RKI-Ratgeber (2007) Toxoplasmose. Epidemiologischen Bulletin: 40/2007
Romand S, Wallon M, Franck J, Thulliez P, Peyron F, Dumon H (2001) Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet Gynecol 97:296–300
Roos T, Martius J, Gross U, Schrod L (1993) Systematic serologic screening for toxoplasmosis in pregnancy. Obstet Gynecol 81:243–250
Roser D, Nielsen HV, Petersen E, Saugmann-Jensen P, Norgaard-Pedersen B (2010) Congenital toxoplasmosis--a report on the Danish neonatal screening programme. J Inherit Metab Dis 33:241–247
Rudin C, Boubaker K, Raeber PA, Vaudaux B, Bucher C, Garweg JG, Hoesli I, Kind I, Hohlfeld P (2008) Swiss Working Group on congenital Toxoplasmosis. Toxoplasmosis during pregnancy and infancy. A new approach for Switzerland. . Swiss Med Wkly 138:1–8
Sanchez VR, Pitkowski MN, Fernandez Cuppari AV, Rodriguez FM, Fenoy IM, Frank FM, Goldman A, Corral RS, Martin V (2011) Combination of CpG-oligodeoxynucleotides with recombinant ROP2 or GRA4 proteins induces protective immunity against Toxoplasma gondii infection. Exp Parasitol 128:448–453
Strauss A (2008) Ultraschallpraxis Gynäkologie und Geburtshilfe. Springer, Heidelberg
Syrocot, Thiebaut R, Leproust S, Chene G, Gilbert R (2007) Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients’ data. Lancet 369:115–122
Tenter AM, Fehlhaber K (2002) Toxoplasmose: Eine lebensmittelübertragene Parasitose. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 45:549–555
Tenter AM, Heckeroth AR, Weiss LM (2000) Toxoplasma gondii: from animals to humans. Int J Parasitol 30:1217–1258
Villena I, Ancelle T, Delmas C, Garcia P, Brezin AP, Thulliez P, Wallon M, King L, Goulet V (2010) Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill 15:
Wallon M, Kodjikian L, Binquet C, Garweg J, Fleury J, Quantin C, Peyron F (2004) Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics 113:1567–1572
Wilson CB, Remington JS, Stagno S, Reynolds DW (1980) Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics 66:767–774
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Mylonas, I., Groß, U., Hlobil, H., Friese, K., Wintergerst, U. (2013). Toxoplasmose. In: Friese, K., Mylonas, I., Schulze, A. (eds) Infektionserkrankungen der Schwangeren und des Neugeborenen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-78325-1_37
Download citation
DOI: https://doi.org/10.1007/978-3-540-78325-1_37
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-78324-4
Online ISBN: 978-3-540-78325-1
eBook Packages: Medicine (German Language)